Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Osama Ashry Ahmed Gheith"'
Autor:
Tarek Zakaria El Baz, Osama Ahmed Khamis, Osama Ashry Ahmed Gheith, Salama Saad Abd Ellateif, Abdallah Mahmoud Abdallah, Hussein Chahine Abd El Aal
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 28, Iss 1, Pp 51-60 (2017)
More than half of deaths in end-stage kidney disease (ESKD) patients are due to cardiovascular disease. Elevated fibroblast growth factor 23 (FGF-23) was found to be associated with mortality in hemodialysis (HD) patients and correlates with peripher
Externí odkaz:
https://doaj.org/article/7bec8ae139784bb2b59b53ba6f80eb42
Autor:
Osama Ashry Ahmed Gheith
Publikováno v:
International Journal of Nephrology, Vol 2011 (2011)
Hepatitis C virus, which usually starts during dialysis therapy, is currently the main cause of chronic liver disease in such population. The majority of patients acquired the disease through intravenous drug use or blood transfusion, with some risk
Externí odkaz:
https://doaj.org/article/9bcd9b162e8c4159b4adc4104ab0e8a2
Autor:
Osama Ashry Ahmed Gheith
Publikováno v:
International Journal of Nephrology, Vol 2011 (2011)
Aim of Review. Huge effort is being made among the transplant community investigating novel biomarkers that enable transplant clinicians to identify patients at risk for allograft rejection or those who will develop tolerance so that immunosuppressio
Externí odkaz:
https://doaj.org/article/a19dc96d2f1f43e28595a3b2863d25ec
Autor:
Torki Alotaibi, Osama Ashry Ahmed Gheith, Medhat MA Halim, Ayman Maher Nagib, Hasaneen Hasaneen Ahmed Aboatya Aboatya, Tarek S.H. Mahmoud, Prasad Nair, Ahmed Atta, Mohamed Abdelmonem, Narayanam Nampoory
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Many studies suggested that chronic allograft nephropathy might progress faster in patients with PTA, but whether full correction of anemia improves renal outcomes is unknown. We aimed to assess the impact of full correction of ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46eb25bcfe96f2ad4b5e64f55b753242
https://doi.org/10.1093/ndt/gfac087.031
https://doi.org/10.1093/ndt/gfac087.031
Autor:
Torki Alotaibi, Osama Ashry Ahmed Gheith, Ayman Maher Nagib, Hasaneen Hasaneen Ahmed Aboatya Aboatya, Medhat MA Halim, Tarek S.H. Mahmoud, Mohamed Emam, Mohamed Mostafa, Zakaria Elsayed, Prasad Nair
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Monoclonal antibodies inhibiting proprotein convertase subtilisin/Kexin type A(PCSK-9) have emerged as one of the new cholesterol-lowering agents. It is not evaluated among renal transplant recipients despite its favorable safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51e0ee8dfe7de04449d9fb991e7feb60
https://doi.org/10.1093/ndt/gfac087.030
https://doi.org/10.1093/ndt/gfac087.030
Autor:
Osama Ashry Ahmed Gheith, Ayman Maher Nagib, Nabil Elserwy, Ahmad Abbas, Islam S Elsawi, Prasad Nair, Mahmoud Khalid, Mohamed Hammad, Zohair Fayyad, Ahmed Atta, Ahmed Mostafa, Ahmed Deraz, Mohamed Abdelmonem, Torki Alotaibi
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Despite the lungs are the major targets of COVID-19, other organs such as the kidneys are also affected. Renal complications of COVID-19 are not yet well studied. We aimed to study the prevalence of acute kidney injury (AKI) among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e9723426bf8ab733dee0c986a48cdb7
https://doi.org/10.1093/ndt/gfac068.007
https://doi.org/10.1093/ndt/gfac068.007